Cargando…
Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide and is heterogeneous both morphologically and molecularly. In an era of personalized medicine, the greatest challenge is to predict individual response to therapy and distinguish patients likely to be cured with surgical res...
Autores principales: | Koulis, Christine, Yap, Raymond, Engel, Rebekah, Jardé, Thierry, Wilkins, Simon, Solon, Gemma, Shapiro, Jeremy D., Abud, Helen, McMurrick, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225926/ https://www.ncbi.nlm.nih.gov/pubmed/32231042 http://dx.doi.org/10.3390/cancers12040812 |
Ejemplares similares
-
Modeling colorectal cancer: A bio‐resource of 50 patient‐derived organoid lines
por: Engel, Rebekah M, et al.
Publicado: (2022) -
Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes Following Chemotherapeutic Treatment
por: Engel, Rebekah M., et al.
Publicado: (2020) -
ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer
por: Jardé, Thierry, et al.
Publicado: (2015) -
The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients
por: Yap, Raymond, et al.
Publicado: (2016) -
SRSF3 shapes the structure of miR‐17‐92 cluster RNA and promotes selective processing of miR‐17 and miR‐20a
por: Ratnadiwakara, Madara, et al.
Publicado: (2023)